Citations as recorded by:

1. Epigenetic silencing of protocadherin 10 in colorectal cancer

Oncol Lett, 2017, 13 p. 2449

DOI: 10.3892/ol.2017.5733

Citations as recorded by: PMC Google

2. 胃癌组织原钙黏蛋白 10 mRNA 表达水平与预后的相关性

Year: 2017

Citations as recorded by: Google

3. Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients

Med Sci Monit, 2016, 22 p. 516

DOI: 10.12659/MSM.897179

Citations as recorded by: Cross Ref PMC Google

4. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

Mol Diagn Ther, 2016, 20(6) p. 531

DOI: 10.1007/s40291-016-0231-2

Citations as recorded by: Cross Ref Google

5. Javier C. Angulo, Jose I. López &

Year: 2016

Citations as recorded by: Google

6. APC methylation predicts biochemical recurrence of patients with prostate cancer: a meta-analysis

Int J Clin Exp Med, 2015, 8 p. 15575

Citations as recorded by: PMC Google

7. NUDT11 rs5945572 polymorphism and prostate cancer risk: a meta-analysis

Int J Clin Exp Med, 2015, 8 p. 3474

Citations as recorded by: PMC Google

8. PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway

34(2) p. 747

DOI: 10.3892/or.2015.4056

Citations as recorded by: Cross Ref Google

9. Polymorphisms in NFKB1 and NFKBIA Genes Modulate the Risk of Developing Prostate Cancer among Han Chinese

Med Sci Monit, 2015, 21 p. 1707

DOI: 10.12659/MSM.893471

Citations as recorded by: Cross Ref PMC Google

10. Effect of Cnidium Lactone on Serum Mutant P53 and BCL-2/BAX Expression in Human Prostate Cancer Cells PC-3 Tumor-Bearing BALB/C Nude Mouse Model

Med Sci Monit, 2015, 21 p. 2421

DOI: 10.12659/MSM.893745

Citations as recorded by: Cross Ref PMC Google

11. Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.

Med. Sci. Monit., 2015, 21 p. 3

Citations as recorded by: Google

12. PCDH10, a novel p53 transcriptional target in regulating cell migration

Cell Cycle, 2015, 14(6) p. 857

DOI: 10.1080/15384101.2015.1004935

Citations as recorded by: Cross Ref PMC Google

13. Bedeutung der PTEN-Deletion zur Stratifizierung von Prostatakarzinomen in klinisch relevanten Subgruppen

Year: 2015

Citations as recorded by: Google

14. Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non Muscle Invasive Bladder Cancer

Med Sci Monit, 2014, 20 p. 1572

DOI: 10.12659/MSM.892130

Citations as recorded by: Cross Ref PMC

15. Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma

Med Sci Monit, 2014, 20 p. 2380

DOI: 10.12659/MSM.892433

Citations as recorded by: Cross Ref PMC Google

16. Identification of γ-Synuclein as a Stage-Specific Marker in Bladder Cancer by Immunohistochemistry

Med Sci Monit, 2014, 20 p. 2550

DOI: 10.12659/MSM.892927

Citations as recorded by: Cross Ref PMC Google

17. Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer

Med Sci Monit, 2014, 20 p. 2584

DOI: 10.12659/MSM.893083

Citations as recorded by: Cross Ref PMC Google

18. Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.

Med. Sci. Monit., 2014, 20 p. 1

DOI: 1

Citations as recorded by: Google